ClinicalTrials.gg
CompletedNCT06002763Updated Nov 16, 2026

Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women

An observational study in Well-Being, Psychological, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Completed at 1 site in Canada. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Observational

How we know

Updated Nov 16, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 55 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 156 studies in Psychological Well-Being with a site in Canada — 45 open to participants now, 59 under way, 1 of them phase 3. Psychological Well-Being · Canada.

Enrollment
11th of 27
200 · median 100
Started
2025
with 16 others
Observational
27 of 156
8 open now
Registered
110th of 156
by date
Lead sponsor
6 of 156
Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Among the 156 studies in Psychological Well-Being with a site in Canada, this one is the 11th largest by enrollment of the 27 observational ones that give a count, is one of 17 that started in 2025, is one of 27 observational ones, and was the 110th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

45 of the 156 studies in Psychological Well-Being with a site in Canada are open now. Recruiting first, the newest first:

40 more — sign in →

All 45 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 18 Years to 55 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 156 studies in Psychological Well-Being with a site in Canada, or all of them as a file.
02

Study summary

There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.

This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).

The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.

03

Conditions studied

  • Well-Being, Psychological

Keywords

  • cesarean delivery
  • vaginal delivery
  • postpartum recovery
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old and over
  • singleton births
  • 37 or more weeks gestational age
  • multiparous or nulliparous patients
  • spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia
  • give informed written consent

Exclusion criteria

Exclusion Criteria:

  • refusal to take part
  • are unable to give or have withdrawn consent
  • patients unable to communicate fluently in English
  • patients who are less than 18 years old
  • patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included)
  • patients who were admitted in ICU
  • patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia
  • patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated
  • patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No

Groups and cohorts

  • Vaginal delivery

    Patients who have vaginal deliveries with neuraxial labour analgesia.

    Other: PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) · Other: WHOQoLBREF (World Health Organization Quality of Life Brief Version) · Other: EQ-5D-3L1 (not an acronym)

  • Cesarean delivery

    Patients who have a scheduled cesarean delivery with neuraxial anesthesia.

    Other: PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) · Other: WHOQoLBREF (World Health Organization Quality of Life Brief Version) · Other: EQ-5D-3L1 (not an acronym)

Interventions

  • OtherPROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System)

    PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.

    Also known as: Patient-Reported Outcomes Measurement Information System

  • OtherWHOQoLBREF (World Health Organization Quality of Life Brief Version)

    The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.

    Also known as: World Health Organization Quality of Life Brief Version

  • OtherEQ-5D-3L1 (not an acronym)

    The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

    Also known as: Global state of health numerical rating score 1-100

06

What researchers measure

Primary outcomes

  1. PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score

    The PROMIS survey score at 24 hours postpartum

    Time frame: 24 hours

  2. WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score

    The WHOQoLBREF survey score at 24 hours postpartum

    Time frame: 24 hours

  3. EQ-5D-3L1 (not an acronym) survey score

    The EQ-5D-3L1 survey score at 24 hours postpartum

    Time frame: 24 hours

  4. PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score

    The PROMIS survey score at 2 weeks postpartum

    Time frame: 2 weeks

  5. WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score

    The WHOQoLBREF survey score at 2 weeks postpartum

    Time frame: 2 weeks

  6. EQ-5D-3L1 (not an acronym) survey score

    The EQ-5D-3L1 survey score at 2 weeks postpartum

    Time frame: 2 weeks

  7. PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score

    The PROMIS survey scores at 6 weeks postpartum

    Time frame: 6 weeks

  8. WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score

    The WHOQoLBREF survey score at 6 weeks postpartum

    Time frame: 6 weeks

  9. EQ-5D-3L1 (not an acronym) survey score

    The EQ-5D-3L1 survey score at 6 weeks postpartum

    Time frame: 6 weeks

  10. PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score

    The PROMIS survey score at 12 weeks postpartum

    Time frame: 12 weeks

  11. WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score

    The WHOQoLBREF survey score at 12 weeks postpartum

    Time frame: 12 weeks

  12. EQ-5D-3L1 (not an acronym) survey score

    The EQ-5D-3L1 survey score at 12 weeks postpartum

    Time frame: 12 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Jan 2026, 6 months.

Of 152 non-industry observational studies under Psychological Well-Being, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 155. This study's 6 months is below that.

Counting every sponsor, half of 161 studies reached it within 30 months; a quarter within 13 and three quarters within 155.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2026 → Jan 2026 and completion Jul 2026 → Apr 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 16, 2023
First posted
Aug 21, 2023
StartActual
Jul 9, 2025
Primary completionActual
Jan 16, 2026was Jul 2026
CompletionActual
Apr 30, 2026was Jul 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 16, 2026
Primary completion
Jul 2026→Jan 16, 2026 (actual)
Nov 16, 2026
Study completion
Jul 2026→Apr 30, 2026 (actual)
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Recruiting→Completed
    Primary completion Jul 2026→Jan 16, 2026 (now actual)
    Study completion Jul 2026→Apr 30, 2026 (now actual)
    + 4 other changes: verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06002763
Responsible party
Sponsor
First posted
Aug 21, 2023
Start date
Jul 9, 2025
Primary completion
Jan 16, 2026
Completion
Apr 30, 2026
Last update
Nov 16, 2026

Study contacts

Ronald George, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion